U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Quiescent proliferative retinopathy due to diabetes mellitus

MedGen UID:
676490
•Concept ID:
C0730281
•
Disease or Syndrome
Synonyms: Inactive PDR (proliferative diabetic retinopathy); Inactive proliferative diabetic retinopathy; Proliferative diabetic retinopathy - quiescent
SNOMED CT: Quiescent proliferative retinopathy due to diabetes mellitus (312908007); Proliferative diabetic retinopathy - quiescent (312908007); Inactive proliferative diabetic retinopathy (312908007); Inactive PDR (proliferative diabetic retinopathy) (312908007)

Recent clinical studies

Etiology

Real-Time Photographic- and Fluorescein Angiographic-Guided Management of Diabetic Retinopathy: Randomized PRIME Trial Outcomes.
Yu HJ, Ehlers JP, Sevgi DD, Hach J, O'Connell M, Reese JL, Srivastava SK, Wykoff CC
Am J Ophthalmol 2021 Jun;226:126-136. Epub 2021 Jan 30 doi: 10.1016/j.ajo.2021.01.024. PMID: 33529593
Factors predicting final visual outcome in quiescent proliferative diabetic retinopathy.
Kim J, Park IW, Kwon S
Sci Rep 2020 Oct 14;10(1):17233. doi: 10.1038/s41598-020-74184-9. PMID: 33057083Free PMC Article
Optical Coherence Tomography Features Of Active And Inactive Retinal Neovascularization In Proliferative Diabetic Retinopathy.
Vaz-Pereira S, Zarranz-Ventura J, Sim DA, Keane PA, Smith R, Egan CA, Tufail A
Retina 2016 Jun;36(6):1132-42. doi: 10.1097/IAE.0000000000000869. PMID: 26630315
Epiretinal membrane inflammatory cell density might reflect the activity of proliferative diabetic retinopathy.
Urbančič M, Štunf Š, Milutinović Živin A, Petrovič D, GlobočnikPetrovič M
Invest Ophthalmol Vis Sci 2014 Nov 25;55(12):8576-82. doi: 10.1167/iovs.13-13634. PMID: 25425310
Clinical course and visual outcome in patients with diabetes mellitus and uveitis.
Oswal KS, Sivaraj RR, Murray PI, Stavrou P
BMC Res Notes 2013 Apr 29;6:167. doi: 10.1186/1756-0500-6-167. PMID: 23628425Free PMC Article

Diagnosis

Case Series: West African Crystalline Maculopathy.
Morettin CE, Ittner EA
Optom Vis Sci 2021 Dec 1;98(12):1403-1407. doi: 10.1097/OPX.0000000000001815. PMID: 34905528
Real-Time Photographic- and Fluorescein Angiographic-Guided Management of Diabetic Retinopathy: Randomized PRIME Trial Outcomes.
Yu HJ, Ehlers JP, Sevgi DD, Hach J, O'Connell M, Reese JL, Srivastava SK, Wykoff CC
Am J Ophthalmol 2021 Jun;226:126-136. Epub 2021 Jan 30 doi: 10.1016/j.ajo.2021.01.024. PMID: 33529593
Optical Coherence Tomography Features Of Active And Inactive Retinal Neovascularization In Proliferative Diabetic Retinopathy.
Vaz-Pereira S, Zarranz-Ventura J, Sim DA, Keane PA, Smith R, Egan CA, Tufail A
Retina 2016 Jun;36(6):1132-42. doi: 10.1097/IAE.0000000000000869. PMID: 26630315
Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy.
Funatsu H, Yamashita H, Nakanishi Y, Hori S
Br J Ophthalmol 2002 Mar;86(3):311-5. doi: 10.1136/bjo.86.3.311. PMID: 11864890Free PMC Article
Screening for diabetic retinopathy using digital colour photography and oral fluorescein angiography.
Newsom R, Moate B, Casswell T
Eye (Lond) 2000 Aug;14 ( Pt 4):579-82. doi: 10.1038/eye.2000.146. PMID: 11040903

Therapy

Real-Time Photographic- and Fluorescein Angiographic-Guided Management of Diabetic Retinopathy: Randomized PRIME Trial Outcomes.
Yu HJ, Ehlers JP, Sevgi DD, Hach J, O'Connell M, Reese JL, Srivastava SK, Wykoff CC
Am J Ophthalmol 2021 Jun;226:126-136. Epub 2021 Jan 30 doi: 10.1016/j.ajo.2021.01.024. PMID: 33529593
Protective effect of Soluble Epoxide Hydrolase Inhibition in Retinal Vasculopathy associated with Polycystic Kidney Disease.
Lin J, Hu J, Schlotterer A, Wang J, Kolibabka M, Awwad K, Dietrich N, Breitschopf K, Wohlfart P, Kannt A, Lorenz K, Feng Y, Popp R, Hoffmann S, Fleming I, Hammes HP
Theranostics 2020;10(17):7857-7871. Epub 2020 Jun 22 doi: 10.7150/thno.43154. PMID: 32685025Free PMC Article
Succinate increases in the vitreous fluid of patients with active proliferative diabetic retinopathy.
Matsumoto M, Suzuma K, Maki T, Kinoshita H, Tsuiki E, Fujikawa A, Kitaoka T
Am J Ophthalmol 2012 May;153(5):896-902.e1. Epub 2012 Jan 20 doi: 10.1016/j.ajo.2011.10.006. PMID: 22265145
Elevation of angiogenic factor Cysteine-rich 61 levels in vitreous of patients with proliferative diabetic retinopathy.
You JJ, Yang CM, Chen MS, Yang CH
Retina 2012 Jan;32(1):103-11. doi: 10.1097/IAE.0b013e318219e4ad. PMID: 21822163
Screening for diabetic retinopathy using digital colour photography and oral fluorescein angiography.
Newsom R, Moate B, Casswell T
Eye (Lond) 2000 Aug;14 ( Pt 4):579-82. doi: 10.1038/eye.2000.146. PMID: 11040903

Prognosis

Real-Time Photographic- and Fluorescein Angiographic-Guided Management of Diabetic Retinopathy: Randomized PRIME Trial Outcomes.
Yu HJ, Ehlers JP, Sevgi DD, Hach J, O'Connell M, Reese JL, Srivastava SK, Wykoff CC
Am J Ophthalmol 2021 Jun;226:126-136. Epub 2021 Jan 30 doi: 10.1016/j.ajo.2021.01.024. PMID: 33529593
Factors predicting final visual outcome in quiescent proliferative diabetic retinopathy.
Kim J, Park IW, Kwon S
Sci Rep 2020 Oct 14;10(1):17233. doi: 10.1038/s41598-020-74184-9. PMID: 33057083Free PMC Article
Optical Coherence Tomography Features Of Active And Inactive Retinal Neovascularization In Proliferative Diabetic Retinopathy.
Vaz-Pereira S, Zarranz-Ventura J, Sim DA, Keane PA, Smith R, Egan CA, Tufail A
Retina 2016 Jun;36(6):1132-42. doi: 10.1097/IAE.0000000000000869. PMID: 26630315
Epiretinal membrane inflammatory cell density might reflect the activity of proliferative diabetic retinopathy.
Urbančič M, Štunf Š, Milutinović Živin A, Petrovič D, GlobočnikPetrovič M
Invest Ophthalmol Vis Sci 2014 Nov 25;55(12):8576-82. doi: 10.1167/iovs.13-13634. PMID: 25425310
Clinical course and visual outcome in patients with diabetes mellitus and uveitis.
Oswal KS, Sivaraj RR, Murray PI, Stavrou P
BMC Res Notes 2013 Apr 29;6:167. doi: 10.1186/1756-0500-6-167. PMID: 23628425Free PMC Article

Clinical prediction guides

Inflammatory cytokines and retinal nonperfusion area in quiescent proliferative diabetic retinopathy.
Lee MY, Park S, Song JY, Ra H, Baek JU, Baek J
Cytokine 2022 Jun;154:155774. Epub 2022 Apr 26 doi: 10.1016/j.cyto.2021.155774. PMID: 35487091
Factors predicting final visual outcome in quiescent proliferative diabetic retinopathy.
Kim J, Park IW, Kwon S
Sci Rep 2020 Oct 14;10(1):17233. doi: 10.1038/s41598-020-74184-9. PMID: 33057083Free PMC Article
Optical Coherence Tomography Features Of Active And Inactive Retinal Neovascularization In Proliferative Diabetic Retinopathy.
Vaz-Pereira S, Zarranz-Ventura J, Sim DA, Keane PA, Smith R, Egan CA, Tufail A
Retina 2016 Jun;36(6):1132-42. doi: 10.1097/IAE.0000000000000869. PMID: 26630315
Epiretinal membrane inflammatory cell density might reflect the activity of proliferative diabetic retinopathy.
Urbančič M, Štunf Š, Milutinović Živin A, Petrovič D, GlobočnikPetrovič M
Invest Ophthalmol Vis Sci 2014 Nov 25;55(12):8576-82. doi: 10.1167/iovs.13-13634. PMID: 25425310
Expression of thrombospondin-2 as a marker in proliferative diabetic retinopathy.
Abu El-Asrar AM, Nawaz MI, Ola MS, De Hertogh G, Opdenakker G, Geboes K
Acta Ophthalmol 2013 May;91(3):e169-77. Epub 2013 Feb 7 doi: 10.1111/aos.12035. PMID: 23387388

Supplemental Content

Table of contents

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...